Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-07-31

FDA Approved: BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for the combination drug Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate from Actavis Pharma, Inc. The ap…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Butalbital, Acetaminophen, Caffeine and Codeine Phosphate

Snippet

SUPPL AP for BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE (BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE)